Pulmonary · PANCE / PANRE

Pleural Effusion

Pathologic fluid accumulation in pleural space — transudate vs exudate by Light criteria.

Also known as: pleural effusion, transudate, exudate, empyema, hemothorax, chylothorax

Overview

Excess fluid in the pleural space resulting from imbalance between fluid production and absorption. Classified as transudate (systemic factors) or exudate (local pleural disease) using Light criteria.

Epidemiology

Estimated >1.5 million pleural effusions annually in the US. Heart failure is the most common cause overall; malignancy is the most common cause of unilateral exudative effusion in adults >50.

Try two board-style Pleural Effusion questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1PulmonaryMedium
A 68-year-old man presents with a pleural effusion. Thoracentesis yields fluid with a pH of 7.12, glucose of 28 mg/dL, and LDH of 2,800 U/L, and the Gram stain shows gram-positive cocci in chains. Which of the following is the most appropriate immediate management?
  • ARepeat large-volume thoracentesis
  • BIntravenous antibiotics without drainage
  • CReferral for surgical decortication
  • DChest tube drainage with IV antibiotics
Reveal answer & full explanation
Correct answer: D — Chest tube drainage with IV antibiotics
  • ARepeat large-volume thoracentesis
  • BIntravenous antibiotics without drainage
  • CReferral for surgical decortication
  • DChest tube drainage with IV antibiotics

Why chest tube drainage with IV antibiotics is correct

  • The fluid meets empyema criteria: pH <7.2 (7.12), glucose <60 mg/dL (28), markedly elevated LDH (2,800 U/L), and an organism on Gram stain (gram-positive cocci in chains, i.e., Streptococcus)
  • An infected pleural space requires source control, so chest tube drainage must accompany IV antibiotics
  • Antibiotics sterilize but cannot evacuate purulent, low-pH fluid; combined drainage plus antibiotics is the standard of care per current BTS/ACCP parapneumonic effusion guidance

Why the others are wrong

  • Intravenous antibiotics without drainage — antibiotics alone cannot clear an empyema because the loculated purulent space needs mechanical drainage; right-treatment-incomplete-step
  • Repeat large-volume thoracentesis — intermittent needle aspiration cannot keep a thick, reaccumulating purulent space empty; complicated parapneumonic fluid with pH <7.2 and organisms warrants an indwelling catheter or chest tube; right-idea-inadequate-drainage
  • Referral for surgical decortication — video-assisted or open decortication is reserved for empyema that fails tube drainage and antibiotics or for an organized fibrous peel, not for initial management; right-treatment-wrong-sequence
Question 2PulmonaryMedium
A 48-year-old woman with metastatic breast cancer has a large recurrent right pleural effusion. Thoracentesis shows an LDH fluid-to-serum ratio of 0.7, a protein ratio of 0.6, glucose of 45 mg/dL, and cytology positive for adenocarcinoma. Her prognosis is limited, and the lung fails to re-expand after initial drainage. Which of the following is the most appropriate management?
  • AShort-course chest tube drainage
  • BScheduled thoracentesis every 2 weeks
  • CTalc pleurodesis via thoracoscopy
  • DIndwelling tunneled pleural catheter
Reveal answer & full explanation
Correct answer: D — Indwelling tunneled pleural catheter
  • AShort-course chest tube drainage
  • BScheduled thoracentesis every 2 weeks
  • CTalc pleurodesis via thoracoscopy
  • DIndwelling tunneled pleural catheter

Why Indwelling tunneled pleural catheter is correct

  • This is a malignant pleural effusion: exudative by Light criteria (LDH ratio 0.7, protein ratio 0.6) with malignant cytology, and the low glucose of 45 mg/dL indicates extensive pleural tumor burden
  • The lung fails to re-expand after initial drainage (non-expandable or trapped lung), which defeats any strategy that depends on apposition of the visceral and parietal pleura
  • Per current ATS and BTS pleural disease guidance, an indwelling tunneled pleural catheter is the preferred option for recurrent malignant effusion with a non-expandable lung — it controls dyspnea with home drainage and minimizes hospitalization in a patient with limited prognosis

Why the others are wrong

  • Talc pleurodesis via thoracoscopy — the definitive first-line choice for malignant effusion with an expandable lung, but the non-expandable lung prevents pleural apposition so the talc cannot create symphysis; right-diagnosis-wrong-step
  • Short-course chest tube drainage — relieves dyspnea today, but a large recurrent effusion predictably reaccumulates once the tube is removed; premature closure on temporary relief
  • Scheduled thoracentesis every 2 weeks — reasonable only for slow reaccumulation in the final days to weeks of life; anchoring on the phrase "limited prognosis" misses that a large, rapidly recurring effusion with a trapped lung is better palliated by a catheter
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Pleural Effusion outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Heart failure, cirrhosis, nephrotic syndrome (transudate)
  • Pneumonia (parapneumonic), malignancy, PE, tuberculosis (exudate)
  • Connective tissue disease (RA, SLE), drugs (amiodarone, methotrexate, nitrofurantoin)
  • Abdominal processes: pancreatitis, subphrenic abscess, ovarian (Meigs syndrome)
  • Hemothorax: trauma, post-procedural, aortic dissection
  • Chylothorax: thoracic duct injury (surgery, trauma), lymphoma, LAM

Pathophysiology

Transudate: imbalance of hydrostatic and oncotic pressures with intact pleura — heart failure, cirrhosis, nephrotic syndrome. Exudate: increased pleural capillary permeability or impaired lymphatic drainage from inflammation, infection, or malignancy.

Clinical presentation

Symptoms

  • Dyspnea (proportional to size and rate of accumulation)
  • Pleuritic chest pain (more with exudates)
  • Cough (often dry)
  • Symptoms of underlying disease: fever (infection), weight loss (malignancy), orthopnea (HF)

Signs / physical exam

  • Decreased breath sounds, dullness to percussion, decreased tactile fremitus over effusion
  • Egophony at upper border (compressive atelectasis)
  • Pleural friction rub may precede or follow effusion
  • Tracheal deviation away (massive effusion)

Differential diagnosis

  • Pneumonia with parapneumonic effusion — Fever, infiltrate; pleural fluid neutrophilic; if complicated (pH <7.2, glucose <40, LDH >1000, pus) → chest tube
  • Malignant pleural effusion — Lung, breast, lymphoma; lymphocytic exudate with cytology+, may be large and recurrent
  • Heart failure — Bilateral (R>L), transudate, BNP elevated; resolves with diuresis
  • PE — Small unilateral exudate in ~20-50% of PE; often missed without dedicated imaging
  • Tuberculous pleuritis — Lymphocytic exudate, elevated ADA (>40 U/L), AFB rarely positive; pleural biopsy with granulomas diagnostic
  • Cirrhotic (hepatic) hydrothorax — Right-sided transudate from diaphragmatic defect; ascites usually present
  • Chylothorax — Milky fluid, triglycerides >110 mg/dL; thoracic duct injury or lymphoma
  • Hemothorax — Trauma; pleural fluid Hct >50% of serum Hct

Diagnostic workup

Diagnostic criteria

Light's criteria — exudate if ANY: pleural fluid protein / serum protein >0.5, pleural fluid LDH / serum LDH >0.6, or pleural fluid LDH > 2/3 upper limit of normal serum LDH. Otherwise transudate (consider serum-pleural albumin gradient >1.2 g/dL to reclassify if patient on diuretics).

Labs

  • Pleural fluid analysis (essential for new unexplained effusion):
  • Cell count and differential
  • Total protein, LDH, glucose, pH
  • Cytology (send large volume if malignancy suspected)
  • Gram stain and culture (aerobic, anaerobic, mycobacterial)
  • Triglycerides if chyle suspected; amylase if pancreatic/esophageal rupture; ADA if TB suspected
  • Serum: simultaneous total protein, LDH, albumin
  • BNP, CBC, BMP, LFTs to characterize underlying disease

Imaging

  • Upright PA/lateral CXR — blunting of costophrenic angle (≥200 mL); lateral decubitus or ultrasound identifies smaller effusions
  • Ultrasound — guides safe thoracentesis (REQUIRED per ATS); identifies loculations
  • CT chest with contrast — characterizes pleural enhancement (malignancy), loculations, mediastinal lymphadenopathy

Diagnostic algorithm

Light's CriterionExudate If…
Pleural fluid protein / serum protein> 0.5
Pleural fluid LDH / serum LDH> 0.6
Pleural fluid LDH> 2/3 upper limit of normal serum LDH
Light's criteria — any one positive defines an exudative pleural effusion (otherwise transudate).

Treatment

First-line

  • Treat the underlying cause: diuresis for HF, antibiotics for parapneumonic, treatment of malignancy
  • Thoracentesis indicated for new effusion of unknown cause (diagnostic) and large symptomatic effusion (therapeutic)
  • Empyema or complicated parapneumonic effusion (pH <7.2, glucose <40, LDH >1000, pus, organism on Gram stain/culture): chest tube drainage; intrapleural tPA + DNase improves outcomes (MIST2)
  • Hemothorax: tube thoracostomy (28-32 Fr); urgent thoracotomy if initial output >1500 mL or ongoing >200 mL/h

Second-line / adjunct

  • Recurrent malignant pleural effusion: indwelling tunneled pleural catheter (PleurX) — outpatient drainage, may achieve auto-pleurodesis; alternative talc pleurodesis via chest tube or VATS
  • TB pleuritis: standard 4-drug RIPE therapy; effusions resolve without drainage in most
  • Refractory hepatic hydrothorax: TIPS or transplant
  • Chylothorax: low-fat MCT diet, octreotide, thoracic duct ligation if refractory

Complications

  • Trapped lung (lung fails to re-expand after drainage → ex-vacuo physiology)
  • Empyema, fibrothorax
  • Re-expansion pulmonary edema (drain ≤1-1.5 L per session)
  • Iatrogenic pneumothorax or hemothorax from thoracentesis (~5% — reduced with ultrasound guidance)

PANCE pearls

  • Light's criteria has high sensitivity for exudate but misclassifies ~25% of HF effusions on diuretics — use serum-pleural albumin gradient >1.2 g/dL to reclassify in that setting.
  • Always use ultrasound guidance for thoracentesis — reduces iatrogenic pneumothorax and dry tap rates substantially.
  • Glucose <60, pH <7.2, and elevated LDH point to empyema, malignancy, RA, or TB.
  • ADA >40 in a lymphocytic exudate strongly suggests TB pleuritis; pleural biopsy with granulomas is diagnostic.
  • Limit single-tap drainage to ~1.0-1.5 L (or until cough/chest discomfort) to avoid re-expansion pulmonary edema.

References

  • BTS 2023 — BTS Clinical Statement on Pleural Disease (Roberts et al., Thorax 2023)
  • MIST2 Trial — Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection (Rahman et al., NEJM 2011)
  • Light Criteria — Pleural Effusions: The Diagnostic Separation of Transudates and Exudates (Light et al., Ann Intern Med 1972)
  • TIME-2 Trial — Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea (Davies et al., JAMA 2012)

Practice Pulmonary questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.